2,781
Views
25
CrossRef citations to date
0
Altmetric
Research Papers

Knowledge, attitudes, beliefs, and behaviors of pregnant women approached to participate in a Tdap maternal immunization randomized, controlled trial

, , , , , & show all
Pages 879-885 | Received 27 Aug 2015, Accepted 06 Dec 2015, Published online: 13 May 2016

References

  • Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005; 24(6 Suppl):S104-8; PMID:15931137; http://dx.doi.org/10.1097/01.inf.0000166154.47013.47
  • Halperin SA, Wang EE, Law B, Mills E, Morris R, Déry P, Lebel M, MacDonald N, Jadavji T, Vaudry W, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991–1997: report of the Immunization Monitoring Program–Active (IMPACT). Clin Infect Dis. 1999;28:1238-43; PMID:10451159; http://dx.doi.org/10.1086/514792
  • Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J. 2009;28:194-8; PMID:19209089; http://dx.doi.org/10.1097/INF.0b013e31818c9032
  • van Hoek AJ, Campbell H, Amirthalingam G, Andrews N, Miller E. The number of deaths among infants under one year of age in England with pertussis: results of a capture/recapture analysis for the period 2001 to 2011. Euro Surveill. 2013;18(9). pii:20414; PMID:23470020
  • Wood N, Siegrist CA. Neonatal immunization: where do we stand? Curr Opin Infect Dis. 2011;24:190-5; PMID:21415741; http://dx.doi.org/10.1097/QCO.0b013e328345d563
  • Wong CY, Thomas NJ, Clarke M, Boros C, Tuckerman J, Marshall HS. Maternal uptake of pertussis cocooning strategy and other pregnancy related recommended immunizations. Hum Vaccin Immunother 2015;11:1165-72; PMID:25874807; http://dx.doi.org/10.1080/21645515.2015.1019188
  • Englund JA. Maternal immunization–Promises and concerns. Vaccine. 2015;33:63723; PMID:26263199; doi: 10.1016/j.vaccine.2015.07.084.
  • Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J. 2010;29:209-15; PMID:20009964; http://dx.doi.org/10.1097/INF.0b013e3181bc98d5
  • Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr. 2008;153:327-32; PMID:18534242; http://dx.doi.org/10.1016/j.jpeds.2008.03.011
  • Quinn HE, Snelling TL, Habig A, Chiu C, Spokes PJ, McIntyre PB. Parental Tdap boosters and infant pertussis: a case-control study. Pediatrics. 2014;134:713-20; PMID:25225136; http://dx.doi.org/10.1542/peds.2014-1105
  • Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52:157-62; PMID:21288837; http://dx.doi.org/10.1093/cid/ciq001
  • Advisory Committee on Immunization Practices. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62(7):131-5; PMID:23425962
  • Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, Ramsay M. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013. Clin Infect Dis. 2015; 60:333-7; PMID:25332078; http://dx.doi.org/10.1093/cid/ciu821
  • Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014; 384(9953):1521-8; PMID:25037990; http://dx.doi.org/10.1016/S0140-6736(14)60686-3
  • National Vaccine Advisory Committee. The National Vaccine Advisory Committee: Reducing patient and provider barriers to maternal immunizations. Public Health Reports. 2015; 130(1), 10-42; PMID:25552752
  • World Health Organization. Vaccines against influenza WHO position paper – November 2012. Wkly Epidemiol Rec. 2012;87:461-76; PMID:23210147
  • Madhi SA, Dangor Z, Heath PT, Schrag S, Izu A, Sobanjo-Ter Meulen A, Dull PM. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013;31(Suppl 4):D52-7; PMID:23973347; http://dx.doi.org/10.1016/j.vaccine.2013.02.029
  • Graham BS, Anderson LJ. Challenges and opportunities for respiratory syncytial virus vaccines. Curr Top Microbiol Immunol. 2013;372:391-404; PMID:24362701; http://dx.doi.org/10.1007/978-3-642-38919-1_20
  • MacDougall DM, Halperin SA. Improving rates of maternal immunization: challenges and opportunities. Hum Vaccin Immunother. 2015 Nov 9 [Epub ahead of print]; PMID:26552807; http://dx.doi.org/10.1080/21645515.2015.1101524
  • Wiley, K. E., Massey, P. D., Cooper, S. C., Wood, N., Quinn, H. E., Leask, J. Pregnant women's intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: A cross sectional survey. Vaccine. 2013;31(37):3972-8; PMID:23777954; http://dx.doi.org/10.1016/j.vaccine.2013.06.015
  • Chamberlain AT, Seib K, Ault KA, Orenstein WA, Frew PM, Malik F, Cortés M, Cota P, Whitney EA, Flowers LC, et al. Factors associated with intention to receive influenza and tetanus, diphtheria, and acellular pertussis (Tdap) vaccines during pregnancy: A focus on vaccine hesitancy and perceptions of disease severity and vaccine safety. PLoS Curr 2015;7. pii: ecurrents.outbreaks.d37b61bceebae5a7a06d40a301cfa819; PMID:25789203; http://dx.doi.org/10.1371/currents.outbreaks.d37b61bceebae5a7a06d40a301cfa819
  • Clark SJ, Adolphe S, Davis MM, Cowan AE, Kretsinger K. Attitudes of US obstetricians toward a combined tetanus-diphtheria-acellular pertussis vaccine for adults. Infect Dis Obstet Gynecol. 2006; 2006:87040 (1-5); PMID:17485814; http://dx.doi.org/10.1155/IDOG/2006/87040
  • Varan AK, Esteves-Jaramillo A, Richardson V, Esparza-Aguilar M, Cervantes-Powell P, Omer SB. Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City. Vaccine. 2014; 32:785-92; PMID:24394441; http://dx.doi.org/10.1016/j.vaccine.2013.12.054
  • Beel ER, Rench MA, Montesinos DP, Mayes B, Healy CM. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother 2013; 9:1926-31; PMID:23782490; http://dx.doi.org/10.4161/hv.25096
  • Halperin BA, MacDougall D, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA. Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: what the Canadian public knows and wants to know. Vaccine. 2015; 33:6840-8; PMID:26392011; http://dx.doi.rog/10.1016/j.vaccine.2015.09.012
  • Statistics Canada. Immigration and ethnocultural diversity in Canada. Available from: http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-010-x/99-010-x2011001-eng.cfm#a3. Accessed 22 August 2015.
  • Statistics Canada. Number and proportion of the population aged 25 to 64 by highest level of educational attainment, Canada, 2011. Available from: http://www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-012-x/2011001/tbl/tbl01-eng.cfm. Accessed 22 August 2015.
  • Halperin BA, Morris A, MacKinnon-Cameron D, Mutch J, Langley JM, McNeil SA, MacDougall D, Halperin SA. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis. 2011; 53:885-92; PMID:21946190; http://dx.doi.org/10.1093/cid/cir538